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Abstract: This study aims to explore the length of stay (LOS) of publicly funded osteoarthritic primary
hip and knee replacement surgeries in New Zealand. Patients with osteoarthritis who underwent
publicly funded primary hip and knee replacement surgery in 2005–2017 were included. We have
identified 53,439 osteoarthritic primary hip replacements and 50,072 osteoarthritic primary knee
replacements. LOS has been reduced by almost 40% over the last 13 years. Logistic regression showed
that women, Māori, Pacific and Asian patients, older patients, people with more comorbidities and
those having opiates on discharge and patients in earlier years were more likely to have extended
LOS following hip replacements and knee replacements. Regional differences were noted in LOS
between the Waitemata District Health Board (DHB) compared to Tairāwhiti DHB where patients
were the most likely to have a LOS of more than 5 days after hip and knee replacements. LOS after
hip and knee replacements has been reduced dramatically. Women, Māori, Pacific and Asian patients,
older patients and people with more comorbidities are more likely to have extended LOS. Patients
dispensed opiates on discharge had a longer LOS. There are great geographical variations in LOS for
primary hip and knee surgeries in New Zealand.
Keywords: hip replacement; knee replacement; osteoarthritis; length of stay
1. Introduction
Osteoarthritis of the hip and knee is one of the most common causes of reduced mobility [1].
In New Zealand, osteoarthritis affects 10.6% of adults [2]. Hip and knee replacements for osteoarthritis
can help alleviate pain and improve function. The New Zealand Joint Registry reports that osteoarthritis
was responsible for 87% of primary hip arthroplasties and 84% of primary knee arthroplasties [3].
The number of hip and knee replacement surgeries in New Zealand has been increasing over time.
There were 8785 primary hip replacement surgeries and 7765 primary knee replacement surgeries
performed in 2016, compared to 4114 and 2429 in 1999, which poses an increasing burden to the
healthcare system [3].
Hospital inpatient costs of arthritis were estimated to be NZ$321 million in 2018, and they were
dominated by osteoarthritic hip and knee surgeries [4]. Length of stay (LOS) for surgery plays an
important role in the costs and the cost-effectiveness of hip and knee surgeries [5–8]. Reduced LOS
following joint replacement surgery is a generalized trend around the world [7,9]. Decreased LOS
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is an indication of reduced costs and increased cost-effectiveness. In a UK study, the LOS dropped
from 16.0 days in 1997 to 5.4 in 2014 for primary knee replacement, and from 14.4 to 5.6 for primary
hip replacement, leading to savings of £1537 and £1412 per patient (without adjusting for inflation)
over the 23 years [7]. A US study reported a cost saving of US$3245 per patient for primary total knee
arthroplasty after shortening the LOS by 0.7 days [8]. The public healthcare resources are limited
and reduction of costs in joint replacement surgeries can lead to more resources for saving lives and
improving quality of life in other health domains.
The New Zealand health care system is a mix of government funded and private health care.
Publicly funded primary hip replacements accounted for 54% of the total number of all primary hip
replacements in 2005–2016, and publicly funded primary knee replacements accounted for 59% of the
total numbers of all primary hip replacements [3]. This study aims to explore the LOS of publicly
funded osteoarthritic hip and knee replacement surgeries in New Zealand and to examine the factors
that influence LOS.
2. Methods
This study included patients with osteoarthritis who underwent publicly funded primary hip and
knee replacement surgery in 2005–2017 [10]. These records were identified from the National Minimum
Dataset (NMD) that stores all publicly funded hospital inpatient and day-patient discharge information
nationally. The ICD-10-AM ACHI Procedure Codes (Version 3) were used to extract the primary
hip and knee replacement surgeries. These records were cross referenced with the New Zealand
Joint Registry [3] data to exclude the admissions not for primary hip or knee replacement surgeries.
The NMD also records patient’s diagnosis for the admission and other comorbidities. Patients without
a diagnosis of osteoarthritis were excluded. Comorbidities for calculating the Charlson comorbidity
index score were identified from the diagnostic codes based on the coding algorithms developed by
Quan et al. [11].
The PHARMS dataset was linked to the NMD through patients’ National Health Index (NHI)
numbers to identify the use of strong opiates after surgeries [12]. The NHI number is a unique identifier
that is assigned to every person who uses health and disability support services in New Zealand.
The PHARMS dataset stores all publicly funded pharmaceutical dispensing records. The strong
opiates included in this study were dihydrocodeine tartrate, fentanyl citrate, fentanyl, methadone
hydrochloride, morphine hydrochloride, morphine sulphate, morphine tartrate, oxycodone pectinate,
oxycodone hydrochloride and pethidine hydrochloride.
We estimated the average LOS after surgery by gender, ethnicity (Māori, Pacific, Asian and
European/others), age group (<40, 40–49, 50–59, 60–69, 70–79 and 80+ years), Charlson comorbidity
index score (0, 1, 2 and 3+), year of surgery, use of opiate or not after surgery and District Health Board
(DHB) where the surgery was performed. There are 20 DHBs in New Zealand. They are responsible for
providing or funding the provision of health services in their district. The public hospitals where these
joint replacement procedures are performed are owned and funded by DHBs. An independent-samples
t-test and one-way ANOVA were used to compare the average LOS between subgroups. We used
two definitions of extended LOS: (1) over 5 days and (2) over 7 days. A logistic regression model was
used to examine the impact of all these factors on extended LOS and estimate the odds ratios after
adjustment for age, gender, ethnicity, Charlson comorbidity index score, year of surgery, use of opiate
or not after surgery and DHB. All data cleaning and analyses were performed in R 3.5.0 ( R Foundation
For Statistical Computing, Vienna, Austria).
3. Results
We identified 53,439 publicly funded osteoarthritic primary hip replacement surgeries and
50,072 osteoarthritic primary knee replacements in 2005–2017 (Table 1). The numbers of hip and knee
replacement surgeries have been increasing over time. Around 93% of primary hip replacements
and 98% of primary knee replacements were performed in patients aged 50+ years. Slightly more
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hip and knee replacement surgeries were performed in women (54.3% hips and 53.3% knees) than
in men. Māori were more likely to have primary hip replacement surgeries than knee replacement
surgeries, but Asian and Pacific people were more likely to have knee replacement surgeries than hip
replacement surgeries. The majority of patients had no severe comorbidities: 87.6% for hip surgeries
and 85.1% for knee surgeries. Twenty-two percent of patients undergoing hip replacement surgeries
and 30.5% of knee replacement patients had strong opiate drugs post operation.
Women had a longer LOS than men (5.3 vs. 4.7 days for hip surgeries and 5.4 vs. 5.1 after knee
surgeries; Table 1). The LOS generally increased with age except for the age group of less than 40 years
old. Māori patients had the shortest LOS than other ethnic groups. However, when we compared the
LOS between ethnic groups after stratifying them by age group (Table 2), Māori and Pacific patients
generally had longer LOS than Europeans and others by age group.
The LOS increased with Charlson score: from 4.8 days for score 0 to 8.3 days for score 3+ for hip
surgeries, and from 5.1 days for score 0 to 7.9 days for score 3+ for knee surgeries (Table 1). Patients
who had opiates after surgery had a longer LOS than those did not have opiates. The overall LOS has
been decreasing over time: from 6.2 days in 2005 to 3.8 days in 2017 for hip surgeries, and from 6.6
days in 2005 to 4.1 days in 2017 for knee surgeries.
South Canterbury DHB (4.3 days) had the shortest LOS after hip surgeries (Table 3), followed
by Nelson–Marlborough DHB (4.4 days) and Capital and Coast DHB (4.6 days). Tairāwhiti DHB (5.9
days), Auckland DHB (5.6 days) and Waikato DHB (5.5 days) had the longest LOS after hip surgeries.
Nelson–Marlborough DHB (4.4 days) had the shortest LOS after knee surgeries, followed by Capital
and Coast DHB (4.8 days) and South Canterbury DHB (4.8 days). Auckland DHB (6.0 days), Wairarapa
DHB (5.9 days) and Tairāwhiti DHB (5.7 days) had the longest LOS after knee surgeries.
For primary hip replacement, 29.9% of patients had a LOS of more than 5 days and 10.5% had
a LOS of more than one week. For primary knee replacement, 34.2% of patients had a LOS of more
than 5 days and 12.4% had a LOS of more than one week. Logistic regression (Tables 4 and 5) showed
that after adjustment, women, Māori, Pacific and Asian patients, older patients, people with more
comorbidities, those having opiates post operation and patients in earlier years were more likely to
have extended LOS in terms of both hip surgeries and knee surgeries. Compared to Waitemata DHB,
patients in Tairāwhiti DHB were the most likely to have a LOS of more than 5 days after hip and knee
surgeries (odds ratio: 4.88 (95% CI: 4.09–5.81) and 2.78 (95% CI: 2.30–3.37) and the most likely to have a
LOS of more than one week after hip surgeries (odds ratio: 3.13 (95% CI: 2.53–3.86)). Compared to
Waitemata DHB, patients in Auckland DHB were the most likely to have a LOS of more than 7 days
after knee surgeries (odds ratio: 1.79 (95% CI: 1.58–2.03). For hip surgeries, South Canterbury DHB
was the least likely to have an extended LOS of more than 5 days (0.75 (95% CI: 0.63–0.88)), and of
more than 7 days (0.46 (95% CI: 0.35–0.61)). For knee surgeries, Nelson–Marlborough DHB was the
least likely to have an extended LOS of more than 5 days (0.56 (95% CI: 0.49–0.64)), and of more than 7
days (0.45 (95% CI: 0.36–0.55)).
Int. J. Environ. Res. Public Health 2019, 16, 4789 4 of 11
Table 1. Length of hospital stay by subgroup.
Subgroup





Mean Median SD p-Value Mean Median SD p-Value
Gender
Female 29,015 (54.3%) 5.3 5 3.3 <0.001 26,698 (53.3%) 5.4 5 2.6 <0.001
Male 24,424 (45.7%) 4.7 4 3.0 23,374 (46.7%) 5.1 4 3.0
Ethnicity
European/others 46,347 (86.7%) 5.0 4 3.2 <0.001 41,799 (83.5%) 5.3 5 2.8 <0.001
Māori 6071 (11.4%) 4.8 4 3.1 3889 (7.8%) 5.1 5 2.8
Pacific 698 (1.3%) 5.0 4 3.5 2477 (4.9%) 5.4 5 3.2
Asian 323 (0.6%) 5.3 4 3.7 1907 (3.8%) 5.4 5 2.5
Age
<40 771 (1.4%) 4.3 4 2.7 <0.001 72 (0.1%) 5.1 5 3.0 <0.001
40–49 3126 (5.8%) 4.2 4 3.0 1130 (2.3%) 4.7 4 2.5
50–59 8733 (16.3%) 4.3 4 2.4 7718 (15.4%) 4.7 4 2.3
60–69 15,830 (29.6%) 4.6 4 2.6 16,973 (33.9%) 4.9 4 2.4
70–79 17,645 (33.0%) 5.2 5 3.0 17,969 (35.9%) 5.4 5 2.9
80+ 7341 (13.7%) 6.7 6 4.7 6210 (12.4%) 6.5 6 3.5
Charlson comorbidity index
0 46,789 (87.6%) 4.8 4 2.8 <0.001 42,603 (85.1%) 5.1 5 2.4 <0.001
1 3504 (6.6%) 6.1 5 4.1 3781 (7.6%) 6.1 5 4.0
2 2213 (4.1%) 6.3 5 4.8 2678 (5.3%) 6.2 5 3.7
3+ 933 (1.7%) 8.3 7 6.9 1010 (2.0%) 7.9 7 5.2
Use of opiate post-op
No 41,500 (77.7%) 4.9 4 3.0 <0.001 34,820 (69.5%) 5.2 5 2.7 <0.001
Yes 11,939 (22.3%) 5.6 4 3.8 15,252 (30.5%) 5.6 5 2.9
Year
2005 3283 (6.1%) 6.2 6 3.2 <0.001 3093 (6.2%) 6.6 6 3.5 <0.001
2006 3400 (6.4%) 6.1 6 3.7 3155 (6.3%) 6.4 6 2.9
2007 3857 (7.2%) 6.1 5 3.3 3573 (7.1%) 6.2 6 3.0
2008 3725 (7.0%) 5.9 5 3.8 3347 (6.9%) 6.1 5 3.0
2009 3946 (7.4%) 5.6 5 3.1 3538 (7.1%) 5.9 5 2.8
2010 3853 (7.2%) 5.5 5 3.6 3438 (6.9%) 5.8 5 2.9
2011 3855 (7.2%) 5.2 5 2.7 3623 (7.2%) 5.5 5 2.7
2012 4000 (7.5%) 4.9 4 3.1 3818 (7.6%) 5.3 5 2.7
2013 4188 (7.8%) 4.6 4 2.9 3750 (7.5%) 5.0 5 2.6
2014 4653 (8.7%) 4.4 4 2.9 4481 (8.9%) 4.6 4 2.5
2015 4626 (8.7%) 4.2 4 2.8 4349 (8.7%) 4.3 4 2.1
2016 4781 (8.9%) 4.0 3 2.9 4644 (9.3%) 4.2 4 2.2
2017 5272 (9.9%) 3.8 3 2.4 5263 (10.5%) 4.1 4 2.1
Overall 53,439 5.0 4 3.2 50,072 5.3 5 2.8
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Table 2. Length of hospital stay by ethnicity after stratifying by age group.
Age Ethnicity





Mean Median SD Mean Median SD
<40
European/others 524 4.1 4 2.3 52 5.3 5 3.2
Māori 169 4.3 4 3.5 9 5.7 5 2.9
Pacific 64 5.0 4 3.7 9 3.8 3 2.4
Asian 14 5.1 5 2.3 2 4.5 4.5 2.1
40–49
European/others 2156 4.2 4 3.0 817 4.7 4 2.6
Māori 784 4.3 4 3.1 191 4.7 4 2.4
Pacific 138 4.0 4 1.9 95 4.6 4 1.7
Asian 48 4.3 4 2.0 27 5.6 5 2.8
50–59
European/others 6721 4.2 4 2.2 5740 4.6 4 2.0
Māori 1740 4.3 4 2.8 1069 4.7 4 2.8
Pacific 208 4.7 4 3.6 623 5.0 4 3.7
Asian 63 5.4 5 5.0 286 5.3 5 2.5
60–69
European/others 13,597 4.6 4 2.6 13,600 4.8 4 2.3
Māori 1997 4.7 4 3.0 1533 5.0 4 2.7
Pacific 149 5.4 5 3.9 1045 5.3 5 2.5
Asian 86 5.0 4 2.8 795 5.3 5 2.3
70–79
European/others 16,237 5.2 5 3.0 15,723 5.4 5 2.9
Māori 1201 5.5 5 3.2 937 5.6 5 2.8
Pacific 118 5.9 5 3.6 636 6.0 5 3.8
Asian 86 5.8 5 3.7 673 5.5 5 2.5
80+
European/others 7112 6.7 6 4.7 5867 6.5 6 3.5
Māori 180 6.4 6 4.4 150 6.4 6 3.1
Pacific 21 6.8 6 4.5 69 6.6 5 3.7
Asian 26 7.0 5 5.0 124 6.2 5 2.9
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Table 3. Length of hospital stay by DHB.
DHB





Mean Median SD Mean Median SD
Northland 2521 5.1 5 3.4 2396 5.6 5 2.9
Waitemata 5021 4.7 4 2.8 600 5.0 4 3.4
Auckland 2630 5.6 5 4.9 3331 6.0 5 3.2
Counties Manukau 4064 4.9 4 3.1 5395 5.3 5 3.2
Waikato 4965 5.5 5 3.5 4731 5.6 5 2.9
Lakes 1581 4.7 4 2.7 1449 4.9 4 2.6
Bay of Plenty 3834 5.3 5 3.6 3375 5.4 5 3.0
Tairāwhiti 786 5.9 5 4.5 572 5.7 6 2.4
Hawkes Bay 2338 5.1 5 3.1 2050 5.1 5 2.5
Taranaki 1725 5.3 5 3.7 1202 5.6 5 2.9
Mid Central 2390 4.9 4 2.5 2275 5.0 4 2.2
Whanganui 1357 5.1 4 2.8 1264 4.9 4 2.5
Capital and Coast 2561 4.6 4 3.1 2696 4.8 4 2.3
Hutt Valley 1539 4.9 5 2.6 1551 5.1 5 2.5
Wairarapa 764 5.2 5 2.8 666 5.9 5 2.9
Nelson–Marlborough 2655 4.4 4 2.3 2108 4.4 4 2.0
West Coast 709 5.1 5 2.3 665 5.4 5 2.3
Canterbury 6081 4.8 4 2.8 4255 5.0 5 2.1
South Canterbury 1327 4.3 4 2.3 999 4.8 4 2.7
Southern 4558 5.2 5 2.8 3068 5.6 5 2.6
Unknown 33 5.8 5 3.3 24 5.3 5 1.6
Overall 53,439 5.0 4 3.2 5072 5.3 5 2.8
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Table 4. Adjusted odds ratio of length of stay over 5 days and 7 days after hip replacement surgeries. †.
Subgroup
Over 5 Days Over 7 Days
p-Value Odds Ratio (95% CI) p-Value Odds Ratio (95% CI)
Gender
Female Ref Ref
Male <0.001 0.67 0.64 0.70 <0.001 0.81 0.76 0.86
Ethnicity
European/others Ref Ref
Māori 0.014 1.10 1.02 1.18 0.002 1.18 1.06 1.31
Pacific <0.001 2.00 1.64 2.43 <0.001 2.06 1.60 2.67
Asian 0.002 1.54 1.17 2.02 0.026 1.50 1.05 2.15
Age <0.001 1.06 1.06 1.07 <0.001 1.07 1.06 1.07
Charlson Comorbidity Index
0 Ref Ref
1 <0.001 1.95 1.80 2.11 <0.001 2.30 2.09 2.53
2 <0.001 2.27 2.06 2.50 <0.001 3.03 2.70 3.39
3+ <0.001 4.42 3.79 5.16 <0.001 5.23 4.51 6.07
Use of opiate post operation
No Ref Ref
Yes <0.001 1.70 1.62 1.79 <0.001 1.68 1.57 1.80
Year (Continuous) <0.001 0.80 0.79 0.80 <0.001 0.84 0.84 0.85
DHB
Northland <0.001 2.33 2.07 2.62 0.001 1.30 1.11 1.53
Waitemata Ref Ref
Auckland <0.001 1.99 1.77 2.24 <0.001 1.66 1.43 1.92
Counties Manukau 0.107 1.09 0.98 1.22 0.900 0.99 0.86 1.14
Waikato <0.001 2.61 2.36 2.88 <0.001 1.50 1.31 1.70
Lakes <0.001 1.61 1.40 1.85 0.288 1.11 0.91 1.35
Bay of Plenty <0.001 2.26 2.04 2.51 0.017 1.19 1.03 1.37
Tairāwhiti <0.001 4.88 4.09 5.81 <0.001 3.13 2.53 3.86
Hawkes Bay 0.068 1.13 0.99 1.28 <0.001 0.70 0.58 0.84
Taranaki <0.001 1.75 1.53 2.00 0.003 1.31 1.09 1.56
Mid Central <0.001 1.37 1.21 1.55 0.015 0.80 0.66 0.96
Whanganui <0.001 1.59 1.37 1.85 0.113 0.84 0.67 1.04
Capital and Coast 0.031 0.87 0.76 0.99 <0.001 0.59 0.49 0.71
Hutt Valley <0.001 1.54 1.34 1.78 0.024 0.78 0.63 0.97
Wairarapa <0.001 2.54 2.12 3.04 0.001 1.50 1.17 1.91
Nelson–Marlborough 0.026 0.87 0.76 0.98 <0.001 0.54 0.44 0.65
West Coast <0.001 2.33 1.93 2.81 0.182 1.20 0.92 1.58
Canterbury 0.181 1.07 0.97 1.18 <0.001 0.52 0.45 0.61
South Canterbury <0.001 0.75 0.63 0.88 <0.001 0.46 0.35 0.61
Southern <0.001 1.78 1.61 1.97 0.002 1.23 1.08 1.41
Unknown 0.021 2.64 1.16 6.04 0.295 1.73 0.62 4.85
† Adjusted for age, gender, ethnicity, Charlson comorbidity index score, year of surgery, use of opiate or not after
surgery and DHB.
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Table 5. Adjusted odds ratio of length of stay over 5 days and 7 days after knee replacement surgeries. †.
Subgroup
Over 5 Days Over 7 Days
p-Value Odds Ratio (95% CI) p-Value Odds Ratio (95% CI)
Gender
Female Ref Ref
Male <0.001 0.76 0.72 0.79 <0.001 0.90 0.85 0.95
Ethnicity
European/others Ref Ref
Māori 0.006 1.12 1.03 1.22 0.016 1.15 1.03 1.28
Pacific <0.001 1.38 1.25 1.52 0.007 1.20 1.05 1.38
Asian <0.001 1.35 1.21 1.51 0.068 1.15 0.99 1.33
Age <0.001 1.05 1.05 1.05 <0.001 1.05 1.05 1.06
Charlson Comorbidity Index
0 Ref Ref
1 <0.001 1.71 1.59 1.85 <0.001 2.02 1.85 2.22
2 <0.001 2.04 1.87 2.22 <0.001 2.34 2.11 2.60
3+ <0.001 3.98 3.44 4.61 <0.001 5.06 4.38 5.83
Use of opiate post operation
No Ref Ref
Yes <0.001 1.65 1.58 1.73 <0.001 1.76 1.65 1.88
Year (Continuous) <0.001 0.80 0.79 0.80 <0.001 0.83 0.83 0.84
DHB
Northland <0.001 1.98 1.78 2.21 <0.001 1.42 1.23 1.64
Waitemata Ref Ref
Auckland <0.001 2.06 1.87 2.28 <0.001 1.79 1.58 2.03
Counties Manukau 0.474 1.03 0.95 1.13 0.849 1.01 0.90 1.14
Waikato <0.001 2.02 1.85 2.21 <0.001 1.54 1.37 1.73
Lakes 0.025 1.17 1.02 1.34 0.430 1.08 0.89 1.30
Bay of Plenty <0.001 1.55 1.40 1.71 0.108 1.12 0.98 1.28
Tairāwhiti <0.001 2.78 2.30 3.37 0.006 1.43 1.11 1.85
Hawkes Bay 0.008 0.85 0.75 0.96 <0.001 0.56 0.47 0.68
Taranaki <0.001 1.96 1.70 2.27 <0.001 1.59 1.33 1.90
Mid Central 0.882 1.01 0.90 1.14 <0.001 0.65 0.54 0.79
Whanganui 0.431 1.06 0.91 1.23 0.002 0.69 0.55 0.87
Capital and Coast 0.017 0.87 0.78 0.98 0.005 0.80 0.68 0.93
Hutt Valley 0.020 1.17 1.03 1.34 0.282 0.90 0.75 1.09
Wairarapa <0.001 2.41 2.01 2.88 <0.001 1.72 1.38 2.16
Nelson–Marlborough <0.001 0.56 0.49 0.64 <0.001 0.45 0.36 0.55
West Coast <0.001 2.07 1.73 2.48 0.266 1.16 0.89 1.49
Canterbury 0.053 0.91 0.82 1.00 <0.001 0.57 0.49 0.66
South Canterbury <0.001 0.73 0.61 0.86 0.027 0.77 0.61 0.97
Southern <0.001 1.61 1.46 1.79 <0.001 1.29 1.13 1.47
Unknown 0.103 2.16 0.86 5.47 0.585 0.65 0.14 3.06
† Adjusted for age, gender, ethnicity, Charlson comorbidity index score, year of surgery, use of opiate or not after
surgery and DHB.
4. Discussions
The average LOS was reduced by 2.4–2.5 days for primary hip and knee replacement surgeries
over the 13 years period (from 2005 to 2017), leading to a cost reduction of approximately NZ$4000 per
surgical case that is 13%–20% of the total cost [13,14]. The total cost savings for all the publicly funded
primary hip and knee replacement surgeries in 2017 were approximately 42 million New Zealand
dollars due to the reduced LOS.
Overseas studies demonstrated the same time trend of LOS following total hip and knee
replacement [7,9]. The average LOS in the UK in 2014 was 5.6 days for primary hip replacement and
5.4 days for primary knee replacement, which were both slightly longer than in NZ: 4.4 days and
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4.6 days respectively. However, the LOS in the US is even shorter: 2.75 days for hip replacement and
2.95 days for knee replacement in 2013 [9].
Improved processes have been shown to reduce LOS [7]. Protocols with an emphasis on recovery
and rehabilitation have been introduced in elective orthopedics, including ‘Accelerated Rehabilitation’,
‘Fast-Track’, ‘Clinical Pathways’ and “Enhanced Recovery After Surgery (ERAS)” programs [15–17].
Many of these programs have been introduced to New Zealand and have contributed to the reduced
LOS [18,19]. The LOS for hip and knee replacements could reduce further, with outpatient hip and
knee replacement surgeries being possible. A US study found that 1-day LOS discharge after total
hip and knee replacement is achievable and did not increase readmissions compared to 2-day LOS
discharge [20].
A key component of every enhanced recovery protocol is the use of multimodal (opioid-sparing)
analgesia involving a combination of different opioid and non-opioid analgesic and non-analgesic
drugs [21]. Multimodal analgesia can reduce postoperative side effects and therefore facilitate the
recovery process after surgery [22]. This study showed that patients who used opiates after hip and
knee surgery had a longer LOS. This may represent higher levels of post-operative pain as well as the
higher levels of inpatient opiate use influencing LOS.
Age at surgery, comorbidities, low income, obesity and female gender have been reported to
be associated with increased LOS [5–7,23–25]. In our study, women had a longer LOS than men,
which was consistent with other studies [6,26,27]. This could be attributed to differences in ways in
which men and women respond to the disease, anesthesia and the surgery or to bias on the part of
healthcare workers [6,26,27]. As expected, the LOS increased with age, because older patients have
more comorbidities and have slower recovery after surgery. It has also been found that older patients
were more likely to have experienced post-operative complications, admission to the intensive care
unit (ICU) and be discharged to a skilled care facility [28]. Asian, Pacific and Māori patients were more
likely to have an extended LOS of more than 5 days and 7 days than European/others after adjustment
for other factors. This may be also related to differences in comorbidities in these groups. In this cohort,
27% of Asian patients, 26% of Pacific patients and 20% of Māori patients had at least one comorbidity,
compared to 12% European/others. Other reasons may include the prevalence of obesity in Māori and
Pacific patients [29]. Obesity is associated with a longer LOS after joint replacements [30].
There are great geographical variations in LOS after primary hip and knee surgeries in New Zealand.
This may be partially explained by the differences in medical centers and the populations in different
DHBs. Expert orthopaedic surgeons in big DHBs may have a shorter length of operation than
generalist orthopaedic surgeons in small DHBs. Length of operation has been shown to increase
the risk of a major complication, resulting in an increased LOS [31]. The Auckland DHB had a high
Pacific population (10.3% vs. 6.5% for the national population), and the Tairāwhiti and Waikato
DHB had a high Māori population (50.3% and 22.8% vs. 15.7% for the national population) [32].
The Nelson–Marlborough and South Canterbury DHB have an older and rural population with lower
Māori and Pacific populations [32].
The strength of this study was that it was based on national datasets including over 100,000 primary
hip and knee replacement surgeries. These datasets collect comprehensive data on patient characteristics,
comorbidities and post discharge pharmaceutical dispensing [10]. One weakness is that this study
did not include certain clinical information, e.g., pre- and postoperative hemoglobin levels and blood
transfusions, which have been found to influence LOS [27]. Another limitation is that some peripheral
centers without specialized services such as an ICU or access to dialysis transfer their high risk and
dialysis patients to a tertiary centre for their surgery or post-op management, which is likely to
influence the LOS but we could not identify these cases. Similarly, we could not identify whether some
hospitals had skilled nursing facilities or extended rehabilitation facilities, which would affect the LOS.
We had no data on social determinants such as whether some patients (such as women) were more
likely to live alone or live without social support might need longer hospital LOS.
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5. Conclusions
LOS has been reduced by almost 40% over the last 13 years, which poses a major cost saving to
the public health system. Women, Māori, Pacific and Asian patients, older patients, people with more
comorbidities and patients in earlier years were more likely to have extended LOS. Patients dispensed
opiates on discharge had a longer LOS. Finally we found there were great geographical variations
in LOS for primary hip and knee surgeries in New Zealand, which was likely to be multifactorial.
LOS might reduce further with outpatient surgeries being possible and enhancement in the current
recovery and rehabilitation programs.
Author Contributions: C.L., D.L., R.L., D.W. and S.P. conceived of and designed the study. C.L. did all the data
cleaning and analyses, and wrote the first draft of the main paper. All the authors discussed the results and were
involved in the critical revisions of the manuscript. All the authors have read and approved the final version of
the manuscript.
Funding: This study was funded by Lottery Health Research (Project number: 106082). The funder was not
involved in any part of this study.
Acknowledgments: We would like to thank the Lottery Health Research for funding this study, and the
New Zealand Joint Registry for providing the data for validation.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Vos, T.; Flaxman, A.D.; Naghavi, M.; Lozano, R.; Michaud, C.; Ezzati, M.; Shibuya, K.; Salomon, J.A.;
Abdalla, S.; Aboyans, V.; et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries
1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2163–2196.
[CrossRef]
2. Ministry of Health. Annual Data Explorer 2017/18: New Zealand Health Survey. 2019 [cited 2019 26 June
2019]. Available online: https://minhealthnz.shinyapps.io/nz-health-survey-2017-18-annual-data-explorer/
_w_0811ceee/_w_e98adb87/#!/home (accessed on 5 May 2019).
3. New Zealand Orthopaedic Association. The New Zealand Joint Registry 17 Year Report; New Zealand
Orthopaedic Association: Wellington, New Zealand, 2016.
4. Deloitte Access Economics. The Economic Cost of Arthritis in New Zealand in 2018; Deloitte Access Economics:
Wellington, New Zealand, 2018.
5. Jane, H.H.; Cleary, R.; Gillespie, W.J.; Pinder, I.M.; Sher, J.L. Are clinical and patient assessed outcomes
affected by reducing length of hospital stay for total hip arthroplasty? J. Arthroplast. 2000, 15, 448–452.
6. Abbas, K.; Umer, M.; Qadir, I.; Zaheer, J.; ur Rashid, H. Predictors of length of hospital stay after total hip
replacement. J. Orthop. Surg. (Hong Kong) 2011, 19, 284–287. [CrossRef]
7. Burn, E.; Edwards, C.J.; Murray, D.W.; Silman, A.; Cooper, C.; Arden, N.K.; Pinedo-Villanueva, R.
Prieto-Alhambra, D. Trends and determinants of length of stay and hospital reimbursement following knee
and hip replacement: Evidence from linked primary care and NHS hospital records from 1997 to 2014.
BMJ Open 2018, 8, e019146. [CrossRef]
8. Barad, S.J.; Howell, S.M.; Tom, J. Is a shortened length of stay and increased rate of discharge to home associated
with a low readmission rate and cost-effectiveness after primary total knee arthroplasty? Arthroplast. Today
2018, 4, 107–112. [CrossRef]
9. Molloy, I.B.; Martin, B.I.; Moschetti, W.E.; Jevsevar, D.S. Effects of the Length of Stay on the Cost of Total
Knee and Total Hip Arthroplasty from 2002 to 2013. J. Bone Joint. Surg. Am. 2017, 99, 402–407. [CrossRef]
10. Chunhuan, L.; David, L.; Sandeep, P.; Douglas, W.; Ross, L. Geographical and ethnic differences of
osteoarthritis-associated hip and knee replacement surgeries in New Zealand: A population-based
cross-sectional study. BMJ Open 2019, 9, e032993.
11. Quan, H.; Sundararajan, V.; Halfon, P. Andrew Fong Coding algorithms for defining comorbidities in
ICD-9-CM and ICD-10 administrative data. Med. Care 2005, 43, 1130–1139. [CrossRef]
12. Ministry of Health. National Collections and Surveys. 2017. Available online: http://www.health.govt.nz/nz-
health-statistics/national-collections-and-surveys (accessed on 5 May 2019).
Int. J. Environ. Res. Public Health 2019, 16, 4789 11 of 11
13. Southern Cross. Total Hip Joint Replacement Surgery. 2017. Available online: https://www.southerncross.co.
nz/group/medical-library/total-hip-joint-replacement-surgery (accessed on 5 May 2019).
14. Southern Cross. Total Knee Joint Replacement Surgery. 2017. Available online: https://www.southerncross.
co.nz/group/medical-library/total-knee-joint-replacement-surgery (accessed on 5 May 2019).
15. Kehlet, H. Fast-track hip and knee arthroplasty. Lancet 2013, 381, 1600–1602. [CrossRef]
16. Maempel, J.F.; Walmsley, P.J. Enhanced recovery programmes can reduce length of stay after total knee
replacement without sacrificing functional outcome at one year. Ann. R. Coll. Surg. Engl. 2015, 97, 563–567.
[CrossRef]
17. Stowers, M.D.; Manuopangai, L.; Hill, A.G.; Gray, J.R.; Coleman, B.; Munro, J.T. Enhanced Recovery After
Surgery in elective hip and knee arthroplasty reduces length of hospital stay. ANZ J. Surg. 2016, 86, 475–479.
[CrossRef]
18. Tarik, S.; Kamran, Z.S.; Abhijith, B.; Arman, K.; Andrew, G.H. A programme of Enhanced Recovery After
Surgery (ERAS) is a cost-effective intervention in elective colonic surgery. N. Z. Med. J. 2010, 123, 61–70.
19. Lemanu, D.P.; Singh, P.P.; Berridge, K.; Burr, M.; Birch, C.; Babor, R.; MacCormick, A.D.; Arroll, B.; Hill, A.G.
Randomized clinical trial of enhanced recovery versus standard care after laparoscopic sleeve gastrectomy.
Br. J. Surg. 2013, 100, 482–489. [CrossRef]
20. Sibia, U.S.; Waite, K.A.; Callanan, M.A.; Park, A.E.; King, P.J.; MacDonald, J.H. Do shorter lengths of stay
increase readmissions after total joint replacements? Arthroplast. Today 2017, 3, 51–55. [CrossRef]
21. White, P.F. Expanding role of multimodal analgesia in facilitating recovery after surgery: From fast-tracking
to enhanced recovery. J. Clin. Anesth. 2019, 55, 105–107. [CrossRef]
22. Chen, J.Y.; Ko, T.L.; Wen, Y.R.; Wu, S.C.; Chou, Y.H.; Yien, H.W.; Kuo, C.D. Opioid-sparing effects of
ketorolac and its correlation with the recovery of postoperative bowel function in colorectal surgery patients:
A prospective randomized double-blinded study. Clin. J. Pain 2009, 25, 485–489. [CrossRef]
23. Epps, C.D. Length stay, discharge disposition, and hospital charge predictors. AORN J. 2004, 79, 975–976.
[CrossRef]
24. Batsis, J.A.; Naessens, J.M.; Keegan, M.T.; Wagie, A.E.; Huddleston, P.M.; Huddleston, J.M. Impact of body
mass on hospital resource use in total hip arthroplasty. Public Health Nutr. 2009, 12, 1122–1132. [CrossRef]
25. El Bitar, Y.F.; Illingworth, K.D.; Scaife, S.L.; Horberg, J.V.; Saleh, K.J. Hospital Length of Stay following
Primary Total Knee Arthroplasty: Data from the Nationwide Inpatient Sample Database. J. Arthroplast. 2015,
30, 1710–1715. [CrossRef]
26. Butterworth, J.; James, R.; Prielipp, R.; Cerese, J.; Livingston, J.; Burnett, D. Female gender associates
with increased duration of intubation and length of stay after coronary artery surgery. CABG Clinical
Benchmarking Database Participants. Anesthesiology 2000, 92, 414–424. [CrossRef]
27. Husted, H.; Holm, G.; Jacobsen, S. Predictors of length of stay and patient satisfaction after hip and knee
replacement surgery: Fast-track experience in 712 patients. Acta Orthop. 2008, 79, 168–173. [CrossRef]
28. Fang, M.; Noiseux, N.; Linson, E.; Cram, P. The Effect of Advancing Age on Total Joint Replacement Outcomes.
Geriatr. Orthop. Surg. Rehabil. 2015, 6, 173–179. [CrossRef]
29. Ministry of Health of New Zealand. Annual Data Explorer 2017/18: New Zealand Health Survey [Data File];
Ministry of Health: Wellington, New Zealand, 2019.
30. Maradit Kremers, H.; Visscher, S.L.; Kremers, W.K.; Naessens, J.M.; Lewallen, D.G. Obesity increases length
of stay and direct medical costs in total hip arthroplasty. Clin. Orthop. Relat. Res. 2014, 472, 1232–1239.
[CrossRef]
31. O’Malley, N.T.; Fleming, F.J.; Gunzler, D.D.; Messing, S.P.; Kates, S.L. Factors independently associated
with complications and length of stay after hip arthroplasty: Analysis of the National Surgical Quality
Improvement Program. J. Arthroplast. 2012, 27, 1832–1837. [CrossRef]
32. Ministry of Health of New Zealand. New Zealand Health System. 2018 [cited 2019 10 July]. Available online:
https://www.health.govt.nz/new-zealand-health-system (accessed on 5 May 2019).
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
